Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Helicobacter Pylori | Research

Nigella sativa powder for helicobacter pylori infected patients: a randomized, double-blinded, placebo-controlled clinical trial

Authors: Hedieh Yousefnejad, Farzaneh Mohammadi, Mahvash Alizadeh-naini, Najmeh Hejazi

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Objective

This double-blind, placebo-controlled, clinical trial was conducted to define the effects of Nigella sativa (N. Sativa) powder plus conventional medical treatment of Helicobacter pylori (H. pylori) on serum ghrelin level and appetite in H. pylori-infected patients.

Methods

In the present study, 51 H. pylori-positive patients were randomly allocated to treatment (n = 26) or placebo (n = 25) groups. They received 2 g/day N. Sativa with quadruple therapy or 2 g/day placebo plus quadruple therapy for 8 weeks. The serum level of ghrelin was assessed before and after the intervention. Appetite was evaluated at the onset and at the end of the intervention.

Results

At the end of the study, the appetite of the treatment group improved significantly compared with the placebo group (P = 0.02). Statistically, the difference in serum ghrelin levels between the study’s groups was insignificant (P > 0.05).

Conclusion

Supplementation with N. Sativa powder may be a beneficial adjunctive therapy in H. pylori-infected patients.

Trial registration

This study was registered in the Iranian Registry of Clinical Trials (IRCT20170916036204N7) on 08/08/2018.
Literature
1.
Khademi F, Poursina F, Hosseini E, Akbari M, Safaei HG. Helicobacter pylori in Iran: a systematic review on the antibiotic resistance. Iran J basic Med Sci. 2015;18(1):2–7.PubMedPubMedCentral
2.
3.
Zamani M, Ebrahimtabar F, Zamani V, Miller W, Alizadeh-Navaei R, Shokri‐Shirvani J, Derakhshan M. Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868–76.CrossRefPubMed
4.
Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol. 2008;23(s2):278–S285.CrossRef
5.
Nweneka CV, Prentice AM. Helicobacter pylori infection and circulating ghrelin levels-a systematic review. BMC Gastroenterol. 2011;11(1):1–18.CrossRef
6.
Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, Tameda M, Shiraki K, Ito M, Takei Y. Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. BMC Gastroenterol. 2016;16(1):1–8.CrossRef
7.
Rezayat F, Hashempur MH, Tavahen H, Salmanroghani H, Emtiazy M. The efficacy of Ramak (a traditional herbal medicine preparation) for patients with ulcerative colitis: a pilot, randomized, triple-blinded, placebo-controlled clinical trial. Eur J Integr Med. 2020;39:101209.CrossRef
8.
Heiran A, Bagheri Lankarani K, Bradley R, Simab A, Pasalar M. Efficacy of herbal treatments for functional dyspepsia: a systematic review and meta-analysis of randomized clinical trials. Phytother Res. 2022;36(2):686–704.CrossRefPubMed
9.
Rao KS, Haran RH, Rajpoot VS. Ethnomedicinal Documentation of Folk Medicinal plants used by tribal Communities living in the selected villages of Pushprajgarh Block of Anuppur District, Madhya Pradesh, Central India. Traditional and Integrative Medicine; 2022.
10.
Mohtashami R, Huseini HF, Heydari M, Amini M, Sadeqhi Z, Ghaznavi H, Mehrzadi S. Efficacy and safety of honey based formulation of Nigella sativa seed oil in functional dyspepsia: a double blind randomized controlled clinical trial. J Ethnopharmacol. 2015;175:147–52.CrossRefPubMed
11.
Darakhshan S, Tahvilian R, Colagar AH, Babolsar I. Nigella sativa: a plant with multiple therapeutic implications. Int J pharmacog. 2015;2:190–214.
12.
Gali-Muhtasib H, El-Najjar N, Schneider-Stock R. The medicinal potential of black seed (Nigella sativa) and its components. Adv Phytomedicine. 2006;2:133–53.CrossRef
13.
Ali B, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2003;17(4):299–305.CrossRef
14.
Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol. 2005;5(13–14):1749–70.CrossRefPubMed
15.
Hashem-Dabaghian F, Agah S, Taghavi-Shirazi M, Ghobadi A. Combination of Nigella sativa and Honey in Eradication of Gastric Helicobacter pylori Infection.Iranian Red Crescent Medical Journal2016, 18(11).
16.
Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM, Randhawa MA. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol. 2010;16(3):207.CrossRefPubMedPubMedCentral
17.
O’Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, Basset C. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005;11(47):7499.CrossRefPubMedPubMedCentral
18.
Ara N, Choudhury S, Amin R. In vitro antimicrobial activity of the volatile oil of Nigella Sativa linn seeds. TAJ: J Teachers Association. 2005;18(2):109–12.
19.
El-Kamali H, Ahmed A, Mohammed A, Yahia A, El-Tayeb I, Ali A. Antibacterial properties of essential oils from Nigella sativa seeds, Cymbopogon citratus leaves and Pulicaria undulata aerial parts. Fitoterapia. 1998;69(1):77–8.
20.
Halawani E. Antibacterial activity of thymoquinone and thymohydroquinone of Nigella sativa L. and their interaction with some antibiotics. Adv Biol Res. 2009;3(5–6):148–52.
21.
Haloci E, Manfredini S, Toska V, Vertuani S, Ziosi P, Topi I, Kolani H. Antibacterial and antifungal activity assessment of Nigella Sativa essential oils. World Acad Sci Eng Technol. 2012;66:2012.
22.
23.
Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM, Randhawa MA. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J gastroenterology: official J Saudi Gastroenterol Association. 2010;16(3):207.CrossRef
24.
Yaxley A, Crotty M, Miller M. Identifying malnutrition in an elderly ambulatory rehabilitation population: agreement between mini nutritional assessment and validated screening tools. Healthcare: 2015:Multidisciplinary Digital Publishing Institute; 2015:pp. 822–829.
25.
Alizadeh-naini M, Yousefnejad H, Hejazi N. The beneficial health effects of Nigella sativa on Helicobacter pylori eradication, dyspepsia symptoms, and quality of life in infected patients: A pilot study.Phytotherapy Research2020.
26.
27.
Choe YH, Lee JH, Lee HJ, Paik KH, Jin DK, Song SY, Lee JH. Ghrelin levels in gastric mucosa before and after eradication of Helicobacter pylori. Gut Liver. 2007;1(2):132.CrossRefPubMedPubMedCentral
28.
Isomoto H, Ueno H, Saenko VA, Mondal MS, Nishi Y, Kawano N, Ohnita K, Mizuta Y, Ohtsuru A, Yamashita S. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol. 2005;100(8):1711–20.CrossRefPubMed
29.
Lee ES, Yoon YS, Park C-Y, Kim H-S, Um TH, Baik HW, Jang EJ, Lee S, Park HS, Oh SW. Eradication of Helicobacter pylori increases ghrelin mRNA expression in the gastric mucosa. J Korean Med Sci. 2010;25(2):265–71.CrossRefPubMedPubMedCentral
30.
31.
Paoluzi OA, Del Vecchio Giovanna Blanco RC, Monteleone I, Monteleone G, Pallone F. Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation. World J Gastroenterology: WJG. 2014;20(3):639.CrossRefPubMedCentral
32.
Weigt J, Malfertheiner P. Influence of Helicobacter pylori on gastric regulation of food intake. Curr Opin Clin Nutr Metabolic Care. 2009;12(5):522–5.CrossRef
33.
Akamizu T, Iwakura H, Ariyasu H, Kangawa K. Ghrelin and functional dyspepsia. International Journal of Peptides 2010, 2010.
34.
Wren A, Seal L, Cohen M, Brynes A, Frost G, Murphy K, Dhillo W, Ghatei M, Bloom S. Ghrelin enhances appetite and increases food intake in humans. 2001.
35.
Fazeli PK, Lawson EA, Faje AT, Eddy KT, Lee H, Fiedorek FT, Breggia A, Gaal IM, DeSanti R, Klibanski A. Treatment with a ghrelin agonist in outpatient women with anorexia nervosa: a randomized clinical trial.The Journal of clinical psychiatry2018, 79(1).
36.
Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature. 2001;409(6817):194–8.CrossRefPubMed
37.
Du L-J, Chen B-R, Kim JJ, Kim S, Shen J-H, Dai N. Helicobacter pylori eradication therapy for functional dyspepsia: systematic review and meta-analysis. World J Gastroenterol. 2016;22(12):3486.CrossRefPubMedPubMedCentral
Metadata
Title
Nigella sativa powder for helicobacter pylori infected patients: a randomized, double-blinded, placebo-controlled clinical trial
Authors
Hedieh Yousefnejad
Farzaneh Mohammadi
Mahvash Alizadeh-naini
Najmeh Hejazi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-03955-4

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue

Study protocol

The effect of an adapted Mindfulness-Based Stress Reduction program on mental health, maternal bonding and birth outcomes in psychosocially vulnerable pregnant women: a study protocol for a randomized controlled trial in a Danish hospital-based outpatient setting

Research

Flowering phenophases influence the antibacterial and anti-biofilm effects of Thymus vulgaris L. essential oil

Research

The changes of neuroactivity of Tui Na (Chinese massage) at Hegu acupoint on sensorimotor cortex in stroke patients with upper limb motor dysfunction: a fNIRS study

Research

A model of purchase intention of complementary and alternative medicines: the role of social media influencers’ endorsements

Research

Total flavonoids of Chrysanthemum indicum L inhibit acute pancreatitis through suppressing apoptosis and inflammation

Research

Effects of laughter yoga on health-related quality of life in cancer patients undergoing chemotherapy: a randomized clinical trial